Clinical Trials Browser

Phase 1/2 × Neuroma, Acoustic × 90 days × Clear all

NCT06517888 2026-03-04

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Phase 1/2 Recruiting

Neuroma, Acoustic, Hearing Loss